HCA Healthcare Stock Forecast

Stock Price Forecast

According to 26 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $459.27. The average 1-year stock price forecast is 1.81% higher than the current stock price, while the lowest is $380 (-15.76%) and the highest is $579 (+28.36%).

Price Target: $459.27 (+1.81%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$380	$459.27	$475.5	$579
Change	-15.76%	+1.81%	+5.41%	+28.36%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	13	13	13	13	14	14
Buy	2	2	1	1	1	1
Hold	9	9	10	10	10	10
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	25	25	25	25	26	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $435 → $496	Buy	Maintains	$435 → $496	+9.96%	Oct 7, 2026
Andrew Mok CFA Barclays	Barclays	Hold Maintains $387	Hold	Maintains	$387	-14.21%	Oct 7, 2026
Lance Wilkes Bernstein	Bernstein	Hold Maintains $426	Hold	Maintains	$426	-5.56%	Oct 5, 2026
Andrew Cooper Raymond James	Raymond James	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Sep 28, 2026
Sean Dodge BMO Capital	BMO Capital	Buy Initiates $495	Buy	Initiates	$495	+9.73%	Sep 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

78.52B

from 75.60B

3.87%

from 75.60B

Revenue Next Year

81.59B

from 78.52B

3.91%

from 78.52B

EPS This Year

29.48

from 28.21

4.50%

from 28.21

EPS Next Year

32.01

from 29.48

8.58%

from 29.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	58.75B	60.23B	64.97B	70.60B	75.60B	78.52B
Revenue Growth	14.01%	2.52%	7.86%	8.67%	7.08%	3.87%
Gross Profit	22.49B	23.18B	25.58B	28.68B	31.37B	32.51B
Gross Margin	38.28%	38.48%	39.37%	40.62%	41.50%	41.40%
Operating Income	9.68B	9.05B	9.63B	10.55B	11.97B	11.95B
Net Income	6.96B	5.64B	5.24B	5.76B	6.78B	6.52B
EPS	-	-	-	-	28.21	29.48
EPS Growth	-	-	-	-	28.46%	4.50%
Forward PE	14.11	13.45	14.25	12.60	15.90	15.30
Dividend / Share	1.92	2.24	2.40	2.64	2.88	3.11
Dividend Growth	346.51%	16.67%	7.14%	10.00%	9.09%	7.90%
Free Cash Flow	-	-	-	-	7.69B	4.90B
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	79.4B
Avg	78.5B
Low	77.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	5.1%
Avg	3.9%
Low	2.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	30.41
Avg	29.48
Low	28.62

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	7.8%
Avg	4.5%
Low	1.5%